- Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model(2025)
Authors: Hannelore Ceuppens, Ana Rita Pombo Antunes, Laurent Navarro, Thomas Ertveldt, Marion Berdal, Surasa Nagachinta, Kirsten De Ridder, Tony Lahoutte, Marleen Keyaerts, Nick Devoogdt, et al.
Pages: 444-457
- Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity(2024)
Authors: Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, Katty Zeven, Dorien Autaers, Ann De Becker, Ivan Van Riet, Cleo Goyvaerts, Sandra Tuyaerts, Bart Neyns, et al.
- Spermatogenesis in mouse testicular organoids with testis-specific architecture, improved germ cell survival and testosterone production(2024)
Authors: Guillaume Richer, Cleo Goyvaerts, Lorna Marchandise, Tamara Vanhaecke, E Goossens, Yoni Baert
- The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis(2024)
Authors: Evelyn Stephany Calderon Espinosa, Kirsten De Ridder, Thomas Benoot, Yanina Jansen, Domien Vanhonacker, Robbe Heestermans, Ann De Becker, Ivan Van Riet, Lore Decoster, Cleo Goyvaerts
- Unraveling resistance mechanisms to immunotherapy in non-small-cell lung cancer(2024)
Authors: Kirsten De Ridder, Cleo Goyvaerts, Karine Breckpot
Number of pages: 192
- Scrutiny of chimeric antigen receptor activation by the extracellular domain(2024)
Authors: Heleen Hanssens, Fien Meeus, Yannick De Vlaeminck, Quentin Lecocq, Janik Puttemans, Pieterjan Debie, Timo W M De Groof, Cleo Goyvaerts, Kim De Veirman, Karine Breckpot, et al.
- In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells(2023)
Authors: Robin Maximilian Awad, Yannick De Vlaeminck, Fien Meeus, Thomas Ertveldt, Katty Zeven, Hannelore Ceuppens, Cleo Goyvaerts, Magali Verdonck, Gustavo Salguero, Geert Raes, et al.
Pages: 1-13
- Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine(2023)
Authors: Thomas Ertveldt, Sofie Meulewaeter, Yannick De Vlaeminck, Oscar Olarte, Katrijn Broos, Serge Van Calenbergh, Stephanie Bourgeois, Joke Deprez, Yves Heremans, Cleo Goyvaerts, et al.
Pages: 5483-5500
- Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment(2023)
Authors: Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout de Mey, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, et al.
Pages: 751-758
- Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment(2022)
Authors: Máté Kiss, Els Lebegge, Aleksandar Murgaski, Helena Van Damme, Daliya Kancheva, Jan Brughmans, Isabelle Scheyltjens, Ali Talebi, Robin Maximilian Awad, Yvon Elkrim, et al.